Gene Query: RP2

Dataset Description Geneva Score
Effect of Hotair overexpression in human breast cancer cell lines 30.53
Induction and Therapeutic Targeting of Human NPM1c+ Myeloid Leukemia in the Presence of Autologous Immune System in Mice 20.33
The hematopoietic master transcription factor PU.1 requires its interaction with the SWI/SNF remodeler to access chromatin de novo 20.25
The hematopoietic master transcription factor PU.1 requires its interaction with the SWI/SNF remodeler to access chromatin de novo [RNA-seq] 20.25
Effect of Influenza virus infection on lncRNA expression in A549 cells 20.18
Inducible three-factor direct reprogramming to nephron progenitors using piggyBac transposons 19.09
VAMP8 contributes to TRIM6-mediated type-I interferon antiviral response upon West Nile virus (WNV) infection 17.45
The splicing factor RBM25 controls MYC activity in Acute Myeloid Leukemia 17.13
Temporal activation of NR5A2 and RARγ induce functional human naïve pluripotent state via modulating TGFβ pathway 15.41
List of TIAM1 differentially expressed genes in SW620 cells [RNA-seq] 14.56
The inhibitory effect of TIAM1 on TAZ transcriptional activity and TIAM1 differentially expressed genes 14.56
IgG immunocomplexes sensitize human monocytes for inflammatory hyperactivity via transcriptomic and epigenetic reprogramming in Rheumatoid Arthritis 14.48
Primary human trophoblast from term placenta 14.39
Trnascriptome analysis of HeLa cells infected with rTHOV-wt, -dML, -SW mutant or mock-treated 13.5
A Novel PI3K Regulator, ARID4B, Presents Synthetic Essentiality in PTEN-deficient Prostate Cancer 13.49
A Novel PI3K Regulator, ARID4B, Presents Synthetic Essentiality in PTEN-deficient Prostate Cancer [RNA-seq] 13.49
Transcriptional profiling of JEG3 cells with HLA-G ablation via deletion of Enhancer L 12.79
RNA-seq in neutrophils from Juvenile Idiopathic Arthritis 12.11
Effect of Hypoxia in Severe Preeclampsia through Epigenetic Regulation 11.03
Gene profiling of human adult and pediatric liver cancer cells 10.77
Tafazzin Regulates Cell State by Modulating Phosphatidylethanolamine and Phosphatidylserine levels 10.77
Catalogue of differentially expressed long non-coding RNAs following activation of human and mouse innate immunity 10.64
SUV420H2 knockdown in PANC-1 10.58
Gene expression in PANC1 cells treated with Rakicidin 10.33
Genome wide expression change by RNF168 knocking down in NEC cells 10.27
Regionally specified human pluripotent stem cell-derived astrocytes 10.15
DHX9 suppresses spurious RNA processing defects originating from the Alu invasion of the human genome [uvCLAP CLIP-seq] 9.9
Major roles of cyclobutane pyrimidine dimers, nucleotide excision repair and ATR in the alternative splicing response to UV irradiation 9.86
Appropriately Differentiated ARPE-19 Cells Regain a Native Phenotype and Similar Gene Expression Profile 9.81
RNA-Sequencing of HepG2 cells treated with TGFBeta 9.6
Human blood CD1c⁺ dendritic cells encompass CD5-high and CD5-low subsets that differ significantly in phenotype, gene expression and functions 9.36
Ribosomal footprinting of MDA-Parental and MDA-LM2 9.27
mRNA sequencing of clinical-grade neural stem cells derived from human ES cells 9.27
Inhibition of TNBC metastasis by Gpx1 9.13
Characterization of transcriptomics landscape in HUVEC cells exposed to oxidative stress (Total RNA) 9.04
Click chemistry enables comprehensive preclinical evaluation of targeted epigenetic therapies [RNA-seq] 8.97
Click chemistry enables comprehensive preclinical evaluation of targeted epigenetic therapies 8.97
Novel Targeting of Transcription and Metabolism in Glioblastoma 8.81
Implication of Long noncoding RNAs in the endothelial cell response to hypoxia revealed by RNA-sequencing. 8.78
Oncogenic Serine-Threonine Kinase Receptor Associated Protein Supports Hepatocellular Carcinoma Cell Growth by Enhancing Wnt/β-catenin Signaling 8.78
The Jumonji-domain histone demethylase inhibitor JIB-04 deregulates oncogenic programs and increases DNA damage in Ewing Sarcoma, resulting in impaired cell proliferation and survival, and reduced tumor growth 8.77
Laminin-guided highly efficient endothelial commitment from human pluripotent stem cells [Bulk RNA-Seq] 8.72
PAK4 suppresses RELB to prevent senescence-like growth arrest in breast cancer 8.45
Stimulation of isolated plasmacytoid dendritic cells (pDCs) with TLR9 agonist CpG C (CpG) and TLR7 agonist imiquimod (IMQ) 8.4
Expression alterations induced by restoration of AXIN1 expression in SNU449 hepatocellular carcinoma cells 8.13
SLIGRL-induced gene expression changes in NHEK cells 8.13
Bromodomain protein BRD4 is a transcriptional repressor of autophagy and lysosomal function 8.04
Interaction with WDR5 recruits MYC to a small cohort of genes required for tumor onset and maintenance 8.02
RNA-seq of cancer-associated fibroblasts (CAF) treated with PBS or extracellular vesicles (EV) from MCF10A or MDA-MB-231 cells 7.88
Expression profiles of long non-coding RNAs located in autoimmune disease-associated regions reveal immune cell type specificity 7.78
Chronic Myeloid Leukemia (CML), induced pluripotent stem cell (iPSC)-derived lin-CD34+CD45+ (iCD34) cell population 7.69
RNA-seq of synchronized S phase or G2 phase cells treated with an ATR inhibitor 7.65
Stem cell and neurogenic gene-expression profiles link prostate basal cells to aggressive prostate cancer 7.65
A role for ZNF598 in post-transcriptional gene regulation 7.45
The effect of engineered del(7q) on induced pluripotent stem cells (iPSCs) derived from patients with Shwachman Diamond Syndrome (SDS). 7.3
CircRNAome diversity in human mature B-cells, T-cells and monocytes 7.29
Dual role of CSL (RBP-Jk) and NOTCH1 in cancer-associated fibroblast genome stability and expansion [RNA-seq] 7.26
Dual role of CSL (RBP-Jk) and NOTCH1 in CAF 7.26
RNA sequencing of lncRNAs knockdown in human pancreatic cancer cell lines 7.11
Ribosomal footprinting of CN34-Parental and CN34-LM1a 7.1
Gene expression, methylome and splicing of THP-1 monocytic cells and THP-1-derived macrophage 7.1
Genome models integrating chromatin contacts and nuclear lamin-genome interactions reveal implications of laminopathy-causing lamin mutations on genome architecture 7.09
Response of HEK293 Freestyle cells to 36 h of culture in Zn(II)-depleted Freestyle medium 7.03
Oncogenic MYC induces a dependency on the spliceosome in human cancer 6.92
LncRNA NMR knockdown and overexpression in esophageal squamous cell carcinoma cell lines 6.89
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 6.89
Rational targeting of cooperating layers of the epigenome yields enhanced therapeutic efficacy against AML 6.86
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma 6.83
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma (RNA-Seq) 6.83
Gata6 potently initiates reprogramming of pluripotent and differentiated cells to extraembryonic endoderm stem cells [ChIP-Seq & RNA-Seq] 6.8
Gata6 potently initiates reprogramming of pluripotent and differentiated cells to extraembryonic endoderm stem cells 6.8
Promoter of lncRNA gene *PVT1* is a tumor suppressor DNA element 6.79
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and PVT1 Knockdown by CRISPRi in MDA-MB-231 human breast cancer cell line 6.79
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer (BRD4_JQ1_RNA-seq) 6.69
Differentially expressed genes during pancreatic bud differentiation in cellular aggregates 6.69
‘Naïve’ ESRRB+ iPSCs with the capacity for rapid neural differentiation 6.66
Single-cell expression profiling reveals new roles for G-protein-coupled receptors in the regulation of Th17 pathogenicity 6.64
IFN-g Regulates mTORC1, Cellular Metabolism and mRNA Translation to Potentiate Inflammatory Macrophage Activation [RNA-Seq] 6.63
IFN-g Regulates mTORC1, Cellular Metabolism and mRNA Translation to Potentiate Inflammatory Macrophage Activation 6.63
The LINC01138 Drives Malignancies via Activating Arginine Methyltransferase 5 in Hepatocellular Carcinoma 6.61
Large-scale expansion of human iPSC-derived skeletal muscle cells for disease modeling and cell-based therapeutic strategies 6.58
The ribonuclease activity of SAMHD1 is required for HIV-1 restriction 6.54
TNF response in promyelocytic and granulocytic forms of HL60/S4 cells 6.43
Effect of OVO-like 1 knockdown on global transcript expression in differentiated BeWo trophoblast cells 6.43
RNA-seq analysis of activated plasmacytoid dendritic cell subsets after viral infection 6.37
Gene expression profiling of leukemia cells following asparagine depletion 6.31
A Basal Stem Cell Signature Identifies Aggressive Prostate Cancer Phenotypes 6.27
Alternative splicing of differentiated myeloid cell transcripts after infection by Anaplasma phagocytophilum impacts a selective group of cellular programs 6.25
Transcriptional profile in human S. haematobium infection 6.16
mRNA cap methyltransferase, RNMT-RAM, promotes RNA pol II transcription 6.16
Adaptive chromatin remodeling in glioblastoma stem cell plasticity and drug tolerance 6.15
Functional interactions between Mi-2β and AP1 complexes control response and recovery from barrier disruption 6.14
Expression profile of HNF1A knockdown and overexpression in 22RV1 and LNCaP cells respectively 6.08
Transcriptional profiling of MDA-MB-231 and its ρ0 cells (lacking mtDNA) after 48h arginine depletion by arginine deiminase (ADI). 5.91
RNA-sequencing of formalin fixed human primary melanoma tissue 5.91
Gene expression profile of regenerated CD8αα T cells and CD8αβ T cells from LMP2 T-iPSCs 5.85
IRF2 is a master regulator of human keratinocyte stem cell fate 5.83
IRF2 is a master regulator of human keratinocyte stem cell fate [RNA-seq] 5.83
HNRNPL and its RNA Targets in Prostate Cancer 5.79
Regulartory effect of HNRNPL and LARP on RNA expression in LNCaP prostate cancer cells 5.79
Gene expression profiling of human MSC-educated macrophages vs. classical macrophages from bone marrow and blood 5.69
Genome-wide Gene Expression Profiling in DLBCL Cell Lines Treated with CUDC-907 5.65
Pharmacological Induction of a Progenitor State for the Efficient Expansion of Primary Human Hepatocytes 5.63
Gene expression changes after depletion of Cyclin F and atypical E2Fs in HeLa cells. 5.62
Functional role of SLIT2 and ROBO1 in trophoblasts 5.6
RNA-seq and m6A-seq of AML cells with FTO knockdown or inhibition 5.6
Genetic-to-epigenetic Therapy for Pancreatic Cancer 5.6
miCLIP, RNA-Seq, and Ribo-Seq in MOLM13 cells 5.59
Evaluation of the immunogenicity of live-attenuated influenza vaccines in nasal epithelial cells in primary differentiated human nasal epithelial cells 5.54
Evaluation of the immunogenicity of live-attenuated influenza vaccines in nasal epithelial cells in primary differentiated human nasal epithelial cells [RNA-Seq] 5.54
Gene expression analysis of airway epithelial cells exposed to flagellin via RNA-seq and microarray 5.48
Gene expression analysis of airway epithelial cells exposed to flagellin via RNA-seq 5.48
A TFIID-SAGA perturbation that targets MYB and suppresses acute myeloid leukemia 5.44
A TFIID-SAGA perturbation that targets MYB and suppresses acute myeloid leukemia (RNA-seq) 5.44
Evolving Spindlin1 Small Molecule Inhibitors Using Protein Microarrays 5.43
Comparison of the transcriptome and chromatin state between human cord blood HSC and human iPSC derived hematopoietic progenitor using next-generation sequencing 5.4
The role of TFEB in retinoid induced differentiation of NB4 APL leukemic cells (shTFEB) 5.38
ASCL1 mediates neuronal differentiation of primary GBM stem cell cultures upon Notch signalling blockade [RNA-seq] 5.32
Transcriptomes of oxLDL exposed trained monocytes 5.32
oxLDL exposed trained monocytes 5.32
A Hybrid Mechanism of Action for BCL6 in B Cells Defined by Formation of Functionally Distinct Complexes at Enhancers and Promoters 5.3
Regionally distinct astrocyte interferon signaling promotes blood-brain barrier integrity and limits immunopathology during neurotropic viral infection 5.29
Transcriptional control of subtype switching ensures adaptation and growth of pancreatic cancer 5.27
RNA-Seq and ATAC-Seq in SMARCD2 k/d NB4 cells with/without ATRA differentiation 5.22
RNA-Seq in SMARCD2 k/d NB4 cells with/without ATRA differentiation 5.22
Zika virus antagonizes interferon response in patients and disrupts RIG-I-MAVS interaction through its CARD-TM domains 5.17
LNCaP treated with iBET 5.14
Direct Isolation and Characterization of Human Nephron Progenitors. 5.13
ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice [HCT116_RNA-seq] 5.1
ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice 5.1
Genomic and proteomic resolution of heterochromatin and its restriction of alternate fate genes (RNA-seq) 5.09
Genomic and proteomic resolution of heterochromatin and its restriction of alternate fate genes 5.09
Human embryonic stem cells in E8 and AKIT culture medium 5.08
Growth factor-free, chemically-defined culture system for expansion and derivation of human pluripotent stem cells 5.08
ER proteostasis and temperature differentially impact the mutational tolerance of influenza hemagglutinin 5.03
ATRX is necessary for cellular senescence and represses HRAS to drive cells from quiescence into senescence [RNA-Seq] 4.93
ATRX is necessary for cellular senescence and represses HRAS to drive cells from quiescence into senescence 4.93
Comparative Analysis of the Transcriptome of Latent Autoimmune Diabetes (LADA) Patients from Eastern China 4.91
The ZZ-type zinc finger of ZZZ3 modulates the ATAC complex-mediated histone acetylation and gene activation 4.89
A potent and selective small-molecule degrader of STAT3 achieves complete tumor regression in vivo 4.87
Integrin signaling regulates YAP/TAZ to control skin homeostasis 4.86
Enhancing human kidney organoid differentiation from pluripotent stem cells with high-throughput automation 4.83
RNA-Seq of LRRK2 G2019S Parkinson’s iPSC-derived astrocytes 4.81
Gene expression changes in THP1 cells at day 2 and 4 following shRNA knock-down of RUVBL2 4.8
Paxillin regulates genomic networks in prostate cancer [LNCaP] 4.75
Histone H3 Lysine4 Acetylation-Methylation Dynamics Define Breast Cancer Subtypes 4.72
Histone H3 lysine 4 acetylation-methylation dynamics define breast cancer subtypes [RNA-seq] 4.72
MBNL1-dependent modulation of gene expression in MDA-MB-231 breast cancer cells 4.68
Muscleblind-like 1 suppresses breast cancer metastatic colonization and stabilizes metastasis suppressor transcripts 4.68
KANK1 inhibits cell growth by inducing apoptosis though regulating CXXC5 in human malignant peripheral nerve sheath tumors 4.6
The ETS transcription factor ELF1 regulates a critical, broadly antiviral program distinct from the type I interferon response 4.6
The ETS transcription factor ELF1 regulates a critical, broadly antiviral program distinct from the type I interferon response 4.6
ARID2 promotes clear cell renal cell carcinoma in the absence of functional PBRM1 4.59
ARID2 promotes clear cell renal cell carcinoma in the absence of functional PBRM1 [RNA-seq] 4.59
Differentially Expressed Genes upon Knockdown of ZRANB1 or EZH2 in LM2 Cells 4.57
Chromatin remodeling mediated by ARID1A is indispensable for normal hematopoiesis in mice (human RNA-Seq) 4.56
Utilizing single-cell variations to reveal environment-dependent tuning of network connectivity in human macrophages (RNA-Seq, CAGE and ChIP-Seq) 4.56
Utilizing single-cell variations to reveal environment-dependent tuning of network connectivity in human macrophages 4.56
RNA-seq of HBV-infected Primary Human Hepatocytes treatment by Tazarotene 4.55
Bacterial Infection Remodels the DNA Methylation Landscape of Human Dendritic Cells (mRNA-Seq) 4.52
TRPS1 shapes YAP/TEAD-dependent transcription in breast cancer cells 4.49
TRPS1 shapes YAP/TEAD-dependent transcription in breast cancer cells [RNA-seq] 4.49
Transcriptomic analysis of LSD1 4.49
Expression changes in melanoma cell lines under BRAFi treatment timepoints [RNA-Seq.CellLine.batch4] 4.49
Disruption of the exocyst induces podocyte loss and dysfunction 4.49
Loss of CREBBP results in gene expression repression in lymphoma cells 4.46
Loss of CREBBP results in H3K27Ac loss at enhancers and gene expression repression in lymphoma cells 4.46
Evolved Labels of Placental Invasion in Human and Bovine Endometrial Stroma 4.42
Ewing sarcoma resistance to SP-2509 is not mediated through KDM1A/LSD1 mutation I 4.36
RNA sequencing of erythroid and granulomonocytic colonies differentiated from transduced bone marrow CD34+ cells expressing U2AF1 S34F mutation, U2AF1 wild-type or empty vector control 4.36
RNA-seq analysis of CRISPR/Cas9 generated human BMPR2 deficient endothelial cell lines harboring mutations characteristic for hereditary pulmonary hypertension (HPAH) 4.35
Epigenomes and transcriptomes of human monocytes before and after in vivo exposure to Bacillus Calmette-Guérin vaccine 4.33
Expression profile and potential functions of circulating long noncoding RNAs in acute ischemic stroke in the Southern Chinese Han population 4.33
Transcriptomic profiling of cleavage-resistant RIPK1 induced autoinflammation syndrome patients 4.32
Open chromatin mapping identifies transcriptional networks regulating human epididymis epithelial function 4.3
Open chromatin mapping identifies transcriptional networks regulating human epididymis epithelial function [Rnase-Seq] 4.3
RNA-sequencing of fibrolamellar carcinoma (FLC) cell line treated with miR-375 mimic 4.28
A map of gene expression in neutrophil-like cell lines 4.27
Identification of a LIF-responsive replication-competent human β cell 4.26
RNA-Seq in neutrophils from Antiphospholipid Syndrome 4.26
Single-cell transcriptomics of the human placenta: inferring the cell communication network of the maternal-fetal interface 4.26
Vitamin d receptor-mediated stromal reprogramming suppresses pancreatitis and enhances pancreatic cancer therapy 4.25
RNA-seq analysis upon ARID1B overexpression 4.23
RNA-sequencing of isogenic primary, pre-malignant immortalized, and Ras-transformed human mammary epithelial cells 4.21
The contribution of adenosine receptor 3-mediated signaling to TLR4-induced responses by human dendritic cells 4.19
Transcriptional profile of CAOV2 ovarian cancer cells with TAZ silencing 4.19
Steroid Receptor Coactivator-2 Regulated Transcriptome in Human Endometrial Stromal Cells 4.18
Topoisomerase 1 inhibition suppresses inflammatory genes and protects from death by inflammation (RNA-Seq) 4.16
Topoisomerase 1 inhibition suppresses inflammatory genes and protects from death by inflammation 4.16
Immune-restricted epigenetic reader SP140 maintains macrophage identity and activation states critical to intestinal homeostasis 4.15
Immune-restricted epigenetic reader SP140 maintains macrophage identity and activation states critical to intestinal homeostasis [RNA-seq] 4.15
LIN28A modulates splicing and gene expression programs in breast cancer cells [RNA-Seq] 4.13
LIN28A modulates splicing and gene expression programs in breast cancer cells 4.13
Effect of CTCF and Rad21 knockdown on SLK cells and KSHV gene expression 4.12
STRIPAK directs PP2A activity to promote oncogenic transformation 4.08
Transcriptomes of human monocytes after ex vivo exposure to uric acid 4.07
Super-enhancer-driven CCAT1 is co-activated by SOX2 and TP63 and promotes squamous cancer from esophagus, head and neck and lung 4.04
Super-enhancer-driven CCAT1 is co-activated by SOX2 and TP63 and promotes squamous cancer from esophagus, head and neck and lung [RNA-seq] 4.04
Genome-wide transcriptome profiling of NEDD9-regulated genes using RNA-seq 4.0
The BCL6 RD2 domain governs commitment of activated B-cells to form germinal centers 4.0
Ribosomal footprinting of MDA_Ctrl and MDA_Arg overexpression cell lines 3.98
MYC interacts with the G9a histone methyltransferase to drive transcriptional repression and tumorigenesis 3.97
Altering cancer transcriptomes using epigenomic inhibitors 3.92
Altering cancer transcriptomes using epigenomic inhibitors [RNA-Seq] 3.92
Allelic expression mapping across cell lineages reveal repressor disruption among disease SNPs 3.91
PTBP1 excludes UPF1 to protect long 3'UTRs from nonsense-mediated mRNA decay 3.9
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [BAA] 3.9
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (separate infection) 3.87
Transcriptome analysis of U87 cells upon LINC00152 knockdown 3.86
C9orf72 Intermediate Repeats are Associated with Corticobasal Degeneration, Increased C9orf72 Expression and Disruption of Autophagy 3.86
Diverse Compounds from Pleuromutilin Lead to a Thioredoxin Inhibitor and Inducer of Ferroptosis 3.85
Genome-wide expression profiling of an in vitro model for studying esophageal epithelial differentiation 3.85
RNA-seq of stable and unstable section of human atherosclerotic plaques 3.82
Effect of estrogen (E2) treatment on the C4-12 relative to the MCF7 cells 3.78
GREB1, a novel target of Wnt signaling, promotes development of hepatoblastoma by suppressing TGFβ signaling 3.78
Quantitative analysis of bi-modal binding of BET proteins at promoters predicts I-BET sensitivity 3.77
The cohesin complex prevents Myc-induced replication stress 3.75
Transcriptome analysis in Neobractatin treated cells 3.74
Patient-derived organoids (PDOs) model treatment response of metastatic gastrointestinal cancers. 3.71
Dysregulated immune system networks in war veterans with PTSD 3.69
Characterization of macrophage - cancer cell crosstalk in estrogen receptor positive and triple-negative breast cancer 3.67
Effect of hypoxia and TGFβ1 on gene expression in HPF fibroblast cells 3.67
RNAseq of PRMT4KD in human cord blood derived CD34+ cells 3.67
Trans-chromosomal regulation by a novel lincRNA required for adipogenesis that escapes X-chromosome inactivation 3.64
Distinct gene expression profile of Huh7 cell lines stably overexpressing CRABP1 or 2 3.61
Transcriptome analysis of virus infected tissues 3.59
Protein kinase A-mediated phosphorylation regulates STAT3 activation and oncogenic EZH2 activity 3.58
Modulation of Indoleamine 2, 3-dioxygenase 1 Expression by Activated Human T cells in Breast Cancer Cells is Controlled by DNA Promoter Methylation 3.56
SETDB1 compacts the inactive X chromosome in part through silencing an enhancer in the IL1RAPL1 gene 3.56
Transcriptome analysis of peripheral blood monocytes 3.53
LSD1 mediates AKT activity in PIK3CA mutant colorectal cancer [RNA-Seq] 3.52
LSD1 mediates AKT activity in PIK3CA mutant colorectal cancer 3.52
SHQ1 regulation of RNA splicing is required for T-lymphoblastic leukemia cell survival 3.5
Chromatin Topology Reorganization and Transcription Repression by PML/RARα in Acute Promyeloid Leukemia (RNA-seq) 3.49
Chromatin Topology Reorganization and Transcription Repression by PML/RARα in Acute Promyeloid Leukemia 3.49
RNA-seq transcriptional profiling in human primary fetal and adult CD34+ hematopoietic stem/progenitor cells (HSPCs) erythroid progenitor cells (ProEs) 3.49
Transcriptional response of human endocervical epithelial A2EN cells to infection with wild-type or CpoS-deficient Chlamydia trachomatis L2/434/Bu 3.48
RNA-seq analysis of FET cells treated with RSPO1 or TGFβ1 3.46
Transcriptome profiling of influenza virus-infected human bronchial epithelial cells 3.45
Insulin induced alterations in chromatin acetylation and transcriptome in triple negative breast cancer cells 3.4
Defective structural RNA processing in relapsing-remitting multiple sclerosis 3.39
JMJD1C is required for the survival of acute myeloid leukemia by functioning as a co-activator for key transcription factors 3.38
RNA expression analysis upon JMJD1C depletion 3.38
MYCL and EP400 are required for Max and MCPyV mediated gene activation 3.37
Vitamin C Promotes Apoptosis in Breast Cancer Cells by Increasing TRAIL Expression 3.37
Global transcriptional analysis of human extended pluripotent stem cells, human primed pluripotent stem cells, mouse extended pluripotent stem cells, and mouse embryonic stem cells by RNA-seq 3.35
Global transcriptional analysis and genome-wide analysis of chromatin state in extended pluripotent stem cells, primed pluripotent stem cells, and naïve pluripotent stem cells 3.35
p38 SAPK and SKIIP induced changes in alternative splicing patterns upon osmostress 3.31
ETV4 is necessary for estrogen signaling and growth in endometrial cancer cells [RNA-seq] 3.3
ETV4 is necessary for estrogen signaling and growth in endometrial cancer cells 3.3
Regulation of protein translation during mitosis 3.28
Global Transcriptional analysis of human spinal cord and neocortical neuroepithelial stem (NES) cells 3.26
Activating PAX Gene Family Paralogs to Complement PAX5 Leukemia Driver Mutations 3.19
Group A Streptococcus M1T1 Intracellular Infection of Primary Tonsil Epithelial Cells Dampens Levels of Secreted IL-8 Through the Action of SpyCEP 3.15
Antibiotics induce polarization of pleural macrophages to M2-like phenotype in patients with tuberculous pleuritis 3.14
Slit2 modifies VEGF-induced angiogenic responses in rabbit skeletal muscle by inducing capillary sprouting and decreasing vascular permeability via reduced eNOS activity 3.09
KSDM1b Role in Ewing Sarcoma 3.07
RNA sequencing of MDA-MB231 and U2OS cancer cell lines exposed to the alkylating agent methyl methanesufonate (MMS) and classical chemotherapeutics  3.06
Physiologic expression of Sf3b1K700E causes impaired erythropoieses, aberrant splicing, and sensitivity to pharmacologic spliceosome modulation 3.06
A comprehensive single cell transcriptional landscape of human hematopoietic progenitors 3.05
Integrative vascular endothelial cell genomics identify AIDA as a coronary artery disease candidate gene 3.04
Integrative vascular endothelial cell genomics identify AIDA as a coronary artery disease candidate gene (RNAseq) 3.04
The cohesin release factor WAPL restricts chromatin loop extension. 3.04
The cohesin release factor WAPL restricts chromatin loop extension. [RNA-Seq] 3.04
mRNAseq of Huntington's disease and control patient iPSC-derived brain microvascular endothelial cells 3.04
Absence of NKG2D ligands defines human leukaemia stem cells and mediates their immune evasion 3.02
Transcriptomic profiling of human HAP1 cells before and after nutrient deprivation 3.01
Human HAP1 cells before and after nutrient deprivation 3.01
The cytokine environment influence on human skin-derived T cells 2.97
Genome wide mapping of long noncoding (lnc) RNAs in hepatic stellate cells 2.96
hnRNP C is a key regulator of protein synthesis in mitosis 2.96
Aging-associated patterns in the expression of human endogenous retroviruses 2.93
RNA-seq analysis of umbilical cord blood cells upon knockdown of NAP1L3 2.89
Reduced CYFIP1 in human neural progenitors as 15q11.2 deletion model: donor specific dysregulation of schizophrenia/epilepsy genes 2.89
Acquisition of a hybrid E/M state is essential for tumorigenicity of basal breast cancer cells 2.89
Transcriptional Signatures of Hypoxic and Inflammatory Renal Epithelial Injury 2.88
Enhancement of direct reprogramming from fibroblasts to epithelial lineages by OVOL2-induced mesenchymal-to-epithelial transition 2.85
Enhancement of direct reprogramming from fibroblasts to epithelial lineages by OVOL2-induced mesenchymal-to-epithelial transition [CAGE] 2.85
Global Long Terminal Repeat activation participates in establishing the unique gene expression program of classical Hodgkin Lymphoma [RNA-Seq] 2.84
Splicing and epigenetic factors jointly regulate epidermal differentiation 2.84
The Short Isoform of BRD4 Promotes HIV-1 Latency by Engaging Repressive SWI/SNF Chromatin Remodeling Complexes 2.8
Single-cell epigenomics maps the continuous regulatory landscape of human hematopoietic differentiation 2.79
Single-cell epigenomics maps the continuous regulatory landscape of human hematopoietic differentiation [bulk RNA-Seq] 2.79
Integrated Systems Biology Analysis of KSHV Latent Infection Reveals Viral Induction and Reliance on Peroxisome Mediated Lipid Metabolism 2.79
CD73 knockdown effect in pancreatic cancer cell lines 2.79
Antibody-Mediated Inhibition of MICA/B Shedding Promotes NK Cell-Driven Tumor Immunity 2.78
Convergent roles of ATF3 and CSL in chromatin control of CAF activation 2.78
Convergent roles of ATF3 and CSL in chromatin control of CAF activation [RNA-seq] 2.78
The Promyelocytic Leukemia Zinc Finger Dependent Transcriptome during Human Endometrial Stromal Cell Decidualization 2.76
Differential susceptibility of human pleural and peritoneal mesothelial cells to asbestos exposure 2.72
RNASeq of MV4;11 cell treated with DMSO, I-BET, SGC0946 and combination of I-BET and SGC0946 2.71
Functional interdependency of BRD4 and DOT1L in MLL leukaemia 2.71
RNA-seq and Hi-C sequencing of neutrophil-like cells migrated through large or small pores 2.71
Migration through a small pore disrupts inactive chromatin organisation in neutrophil-like cells [RNA-seq] 2.71
Dissection of estrogen receptor alpha signaling pathways in osteoblasts using RNA-sequencing 2.71
Leucegene: AML sequencing (part 6) 2.71
Effect of PRDM11 depletion in U2932 cells 2.69
Transcription factor p63 bookmarks genomic loci in epithelial cells and regulates a subset of target genes during epidermal differentiation through dynamic enhancers (RNA-Seq) 2.69
Transcription factor p63 bookmarks genomic loci in epithelial cells and regulates a subset of target genes during epidermal differentiation through dynamic enhancers 2.69
Identification of monocyte-like precursors of granulocytes as a mechanism for accumulation of PMN-MDSC in cancer 2.66
Human Nonsense-Mediated RNA Decay Initiates Widely by Endonucleolysis and Targets snoRNA Host Genes 2.57
Binding to SMN2 pre-mRNA-Protein complex elicits specificity for small molecule splicing modifiers 2.54
The identification of RBM47 binding sites and RBM47-dependent alternative splicing events in brain metastatic breast cancer cells 2.53
Identification of alternatively spliced transcripts in brain metastatic derivatives of MDA-MB-231 breast cancer cells in response to RBM47 expression 2.53
Biosynthesis of histone messenger RNA employs a specific 3' end endonuclease 2.51
Total RNA-seq in ALL-SIL upon TLX1 knockdown 2.5
Dual inhibition of HDMX and HDM2 as a Therapeutic Strategy in Leukemia 2.49
Transcriptome analysis on TDP43 and SRSF3 downstream genes and binding RNAs in MDA-MB231 cells by Next Generation Sequencing 2.49
Role of cervicovaginal microbiota in genital inflammation 2.48
Deletion of DXZ4 on the human inactive X chromosome eliminates superdomains and impairs gene silencing 2.47
RNA-seq of MDA-MB-231 cells with TET1 knockout 2.46
RNA-seq of cells with TET1 knockout 2.46
RNA-SEQ assay for wild type and CRISPR induced endoglin knockout human pulmonary artery smooth muscle cells (PASMC) 2.46
RNA deep sequencing analysis of human brain microvascular endothelial cells (ECs) treated with glioma-conditioned medium (glioma-CM) 2.42
RNASeq of mouse, human, and non-human primate primary dermal fibroblasts to poly(I:C) transfection 2.41
mRNA expression levels in splenic human mononuclear cells of mock- and HIV-1-infected humanized mice 2.39
BBBomics - Human Blood Brain Barrier Transcriptomics Hub [RNA-seq] 2.38
BBBomics - Human Blood Brain Barrier Transcriptomics Hub 2.38
RNA sequencing of human macrophages treated with iron chelator deferiprone (DEF), with and without lipopolysaccharide (LPS) 2.38
Co-regulation of transcription by BRG1 and Brm, two mutually exclusive SWI/SNF ATPase subunits 2.35
Cooperative and Antagonistic Transcriptional Regulation by BRG/BRM [RNA-seq] 2.35
Real-time observation of light-controlled transcription in living cells 2.34
Differential expression of pancreatic cancer PANC1 cells treated with pilocarpine 2.33
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer 2.31
Rational targeting of RNA structure in SMN2 transcripts reverses Spinal Muscular Atrophy molecular phenotypes 2.28
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma [RNA-seq] 2.27
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma 2.27
Differentially expressed genes post knock down of lincDUSP26 2.25
High Resolution Mapping of RNA Polymerases Identifies Mechanisms of Sensitivity and Resistance to BET Inhibitors in t(8;21) AML 2.22
RNA sequencing (RNA-SEQ) of Human endothelial cells (HUVEC) in LFS, sFRP2OE, and WT conditioned media 2.2
A monocyte gene expression signature in the early clinical course of Parkinson’s disease 2.17
A MYC/GCN2/eIF2alpha negative feedback loop limits protein synthesis to prevent MYC-dependent apoptosis in colorectal cancer 2.16
RNA sequencing to study transcriptomic changes in DLD-1 (colorectal adenocarcinoma) cells exposed to soft polyacrylamide matrices (~2 kPa and ~55 kPa) for short time scale of 90 minutes 2.11
Splicing function of mitotic regulators links R-loop mediated DNA damage to tumor cell killing 2.1
IL-21/type I interferon interplay regulates neutrophil-dependent innate immune responses to Staphylococcus aureus 2.1
Interferon-beta-inducible genes in human monocyte-derived macrophages (MDMs) 2.09
Expression of the mannose receptor (CD206) defines distinct populations of human colonic macrophages in health and inflammatory bowel disease 2.07
EZH2 and BCL6 cooperate to assemble CBX8-BCOR Polycomb complex to repress bivalent promoters, mediate germinal center formation and promote lymphomagenesis 2.07
EZH2 and BCL6 cooperate to assemble CBX8-BCOR Polycomb complex to repress bivalent promoters, mediate germinal center formation and promote lymphomagenesis [RNA-seq] 2.07
Identification and characterization of circular RNAs as a new class of putative biomarkers in human blood 2.05
Expression of MERTK based on Multiple Sclerosis (MS) risk haplotype 2.05
Interleukin-1β induces mitochondrial DAMP production to activate STING-dependent innate immune programs 2.04
Decoding breast cancer tissue-stroma interactions using species-specific sequencing 2.04
Truncation of LOC100288798 (SLC38A4-AS) lncRNA in human haploid KBM7 cell line 2.03
RNA-seq study reveals unique transcriptome expression in systemic lupus erythematosus patients with distinct autoantibody profile 2.02
Therapeutic targeting of GCB- and ABC-DLBCLs by rationally designed BCL6 inhibitors 2.01
Inhibitors of the histone methyltransferases EZH2/1 induce a potent antiviral state and suppress infection by diverse viral pathogens [RNA-Seq] 2.0
Inhibitors of the histone methyltransferases EZH2/1 induce a potent antiviral state and suppress infection by diverse viral pathogens 2.0
Integrin αvβ3 acting as membrane receptor for thyroid hormones mediates angiogenesis in malignant T cells 1.98
Dexamethasone inhibits respiratory syncytial virus-driven mucus production while increasing viral replication without altering antiviral interferon signaling 1.94
Newly defined ABCB5+ dermal mesenchymal stem cells promote healing of chronic iron overload wounds via secretion of interleukin-1 receptor antagonist 1.9
Alarmin S100A11 initiates a chemokine response to the human pathogen Toxoplasma gondii 1.88
Bacterial Infection Remodels the DNA Methylation Landscape of Human Dendritic Cells 1.87
Single cell transcriptome of peritoneal cells 1.87
KMT2D regulates p63 target enhancers to coordinate epithelial homeostasis [RNA-Seq] 1.86
KMT2D regulates p63 target enhancers to coordinate epithelial homeostasis 1.86
Effects of transcription on genome - nuclear lamina interactions 1.85
Effects of transcription on genome - nuclear lamina interactions: RNA-seq data 1.85
MicroRNA-125a-5p overexpression in human macrophages 1.84
RUVBL1/RUVBL2 ATPase Activity Drives PAQosome Maturation, DNA Replication and Radioresistance in Lung Cancer 1.84
RNA sequencing based comparative analysis of human hepatic progenitor cells and their niche from alcoholic steatohepatitis livers 1.81
RNASEQ Analysis of sh-TRC and sh-MIR100HG in the triplex negative breast cancer 1.79
Aberrant downstream mechanisms following loss of KMT2C and KMT2D in Pancreatic Ductal Adenocarcinoma 1.79
Hypoxic transcriptome of SQ20B human head and neck cancer cells 1.78
Comparison between THP-1 cells obtained from either ATCC or DSMZ biorepository 1.78
Macrophage Ad5f35 M2 Challenge 1.76
RNA-Seq of CD34+ Bone Marrow Progenitors from Healthy Donors 1.74
The effect of REST and its alternatively spliced transcript, REST-003, on breast cancer invasiveness 1.74
Human SETMAR is a DNA sequence-specific histone-methylase with a broad effect on the transcriptome 1.73
The bromodomain protein BRD4 regulates splicing during heat shock 1.7
RNA G-quadruplexes mark repressive upstream open reading frames in human mRNAs 1.68
Mapping interactions for the TNIP2 hub protein 1.66
Maternal-biased H3K27me3 correlates with paternal-specific gene expression in the human morula 1.62
Race-specific transcriptome and Long non-coding RNA of ADT-resistant African-American prostate cancer cell models. 1.61
A runaway PRH/HHEX-Notch3 feedback loop drives cholangiocarcinoma (RNA-Seq) 1.6
TSLP acts on neutrophils to drive complement-mediated killing of methicillin-resistant Staphylococcus aureus 1.6
Integrated analysis of MLL-AF9 AML patients and model leukemias highlights RET and other novel therapeutic targets (RNA-seq AML development) 1.59
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [Toxin] 1.57
Molecular Hallmarks of Experimentally Acquired Immunity to Malaria [Pilot Study] 1.57
Long noncoding RNA signatures induced by TLR7 and type I IFN signaling in activated human plasmacytoid dendritic cells 1.56
Epigenetic reprogramming of melanoma cells by vitamin C treatment 1.56
Replication defective viral products exploit a cellular pro-survival mechanism to establish persistent infections 1.54
Ribosome profiling upon inhibition of eIF4A 1.49
RNA-seq analysis of Retinoic Acid and Non-treated Control hiPSCs 1.49
RNA-seq on Enasidenib or DMSO Treated CD71+ Cells from Umbilical Cord Blood (UCB) 1.44
Functional significance of the HIV-1 Tat signature amino acid residues 1.43
Time-dependent regulation of cellular programming of monocytes by NCOR2 [RNASeq_KD] 1.42
CT Irradiation Induced Changes of Gene Expression within Peripheral Blood Cells 1.4
FOXP1 orchestration of ASD-relevant signaling pathways. 1.38
The anti-leukemic effect of R-2HG depends on its acting as an m6A mRNA modifier-RNA Seq-Resistant, sensitive and healthy control 1.36
Global gene expression analysis of human monocyte-derived dendritic cells (DCs) treated with HMGN1 (N1) and R848 alone or in combination. 1.36
Transcriptome of Stabilin-1 siRNA transfected human monocytes 1.34
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [UNSWCD] 1.33
Multidimensional Assessment of the Host Response in Mechanically Ventilated Patients with Suspected Pneumonia 1.32
NAPRT activation of macrophages 1.31
Tracking transcriptional changes in a species-specific manner during experimental hepatoblastoma progression in vivo 1.31
Simultaneous profiling of sexually transmitted bacterial pathogens, microbiome, and concordant host response in cervical samples using whole transcriptome sequencing analysis 1.27
Study of dynamic transcriptome profiling in DNA damage-induced cellular senescence and transient cell-cycle arrest 1.25
Investigation about Monocytes in metastatic breast cancer patients under chemotherapy +/- Avastin 1.25
hnRNP L protects mRNAs from nonsense-mediated mRNA decay 1.24
Reprogrammed myeloid cell transcriptomes in NSCLC 1.22
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 1.19
Recapitulating and Deciphering Tumor-stroma Microenvironment by Using a “LEGO” like 3D printed microfluidic device 1.18
Inhibition of the integrin alpha-V beta-3 reverts the paradoxical effect of levothyroxine replacement during bexarotene therapy in cutaneous T-cell lymphoma 1.15
RNA-seq transcriptional profiling in primary human erythroid progenitor cells upon shRNA-mediated knockdown of PRC2 core subunits 1.13
ChIP-seq and RNA-seq analysis of PRC2 core subunits in primary human erythroid progenitor cells 1.13
Histone acetyltransferase p300 induces de novo super-enhancers to drive cellular senescence 1.13
Histone acetyltransferase p300 induces de novo super-enhancers to drive cellular senescence [RNA-seq] 1.13
The mSWI/SNF ATPase module mediates subcomplex identity and non-catalytic targeting in SCCOHT [RNA-seq] 1.11
The ATPase module of mammalian SWI/SNF family complexes mediates subcomplex identity and catalytic activity-independent genomic targeting 1.11
Transcriptional profiling of PBMC from patients with aGvHD and patients without aGvHD after alloHSCT 1.08
Epigenomes and Transcriptomes of human monocytes from Hyper IgD Syndrome (HIDS) patients 1.07
Transcriptome profiling of Caki2 cells re-expressing Polybromo-1 (PBRM1) 1.05
RNA-Seq Samples of siTFE3 in 8988T PDA Cell Line to Investigate Transcriptional Control of the Autophagy-Lysosome System 1.04
Human ovarian granulosa cell transcriptome 1.03
Time series single-cell transcriptomic analysis of AEC2 directed differentiation 1.03
Transcriptome of Primitive Human Hematopoietic Cells: A New Resource to Find hHSC-Specific Genes 1.01
Transcriptome response to 4h IL-1b stimulation of primary chondrocytes 1.01
Complement protein C1q modulates macrophage molecular signaling and inflammatory responses during ingestion of atherogenic lipoproteins 1.0
CNOT1 and Transcriptomic Landscape of a HeLa Cell Line 0.99
RNA-seq in endometrial stromal tumors 0.98
MALT1 Inhibition Is Efficacious in Both Naïve and Ibrutinib-Resistant Chronic Lymphocytic Leukemia. 0.97
Enhancement of Human B Cell Differentiation and Function in Lymph Nodes by the TLR9 Agonist MGN1703 0.97
lncRNA expression analysis in patients with eosinophilic and neutrophilic asthma 0.94
Specific molecular signatures underlie response to decitabine in CMML [RNA-seq] 0.94
Specific molecular signatures underlie response to decitabine in CMML 0.94
Prolyl Hydroxylase Substrate Adenylosuccinate Lyase Is An Oncogenic Driver In Triple Negative Breast Cancer 0.94
Hsa-miR-371a-5p and hsa-miR-518a-3p regulated genes in choriocarcinoma cells 0.94
Expression profiling and occupancy after knockdown or over-expression of HFN1A or HNF4G in prostate cancer cells 0.93
Dynamic developmental signaling logic underlying lineage bifurcations during human endoderm induction and patterning from pluripotent stem cells 0.91
Dynamic developmental signaling logic underlying lineage bifurcations during human endoderm induction and patterning from pluripotent stem cells [Endoderm RNA-seq and ChIP-seq data sets] 0.91
Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock [RNA-Seq] 0.89
Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock 0.89
Engineered Nanointerfaces for Microfluidic Isolation and Molecular Profiling of Tumor-specific Extracellular Vesicles 0.88
Human Bone Marrow Assessment by Single Cell RNA Sequencing, Mass Cytometry and Flow Cytometry [bulk] 0.88
RNA-seq data 0.86
Gene expression profiles in HMC3 cells after exposure to ketamine or its active metabolites: 2R6R-HNK and 2S6S-HNK 0.85
Gene expression profile of human placenta from T. Cruzi infected mothers 0.82
Cockayne syndrome A and B proteins regulate the transcription arrest upon genotoxic stress through a ubiquitin/proteasome degradation process 0.8
Cockayne syndrome A and B proteins regulate the transcription arrest upon genotoxic stress through a ubiquitin/proteasome degradation process (RNA-seq) 0.8
Control of gene expression in senescence through transcriptional read-through of convergent protein-coding genes 0.79
Coronary artery disease genes SMAD3 and TCF21 promote opposing interactive genetic programs that regulate smooth muscle cell differentiation and disease risk [RNA-seq] 0.78
Coronary artery disease genes SMAD3 and TCF21 promote opposing interactive genetic programs that regulate smooth muscle cell differentiation and disease risk 0.78
Tissue-resident memory T cells mediate immune homeostasis in the human pancreas through the PD-1/PD-L1 pathway 0.78
A SRp55-regulated alternative splicing network controls pancreatic beta cell survival and function 0.75
RNA sequencing data of whole blood cells of normal glucose tolerant (NGT) and gestational diabetes (GDM) pregnant women 0.71
RNA-sequencing analysis examining how the Vibrio cholerae MARTX toxin and its inidividual effector domains modulate the transcriptome of human intestinal epithelial cells. 0.71
DHX15 regulates CMTR1-dependent gene expression and cell proliferation 0.68
Viral infection enhances NK cell activation via Type I dependent pathways and can be utilized to enhance influenza-specific monoclonal antibody therapies 0.67
Human naïve pluripotent stem cells exhibit X chromosome dampening and X-inactivation (RNA-Seq) 0.64
The Regulation of IFN Type I Pathway Related Genes RSAD2 and ETV7 Specifically Indicate Antibody-Mediated Rejection After Kidney Transplantation 0.63
Low H3K27me3 and DNA hypomethylation define poorly prognostic pediatric posterior fossa ependymomas 0.62
Discovery of Drug Candidates that Inhibit and Eliminate Zika Virus Infection in Fetal and Adult Brain 0.61
Cancer-Causing Mutations in SF3B1 Alter Splicing by Disrupting Interaction with SUGP1 0.61
Assessing placental maturity through histological and transcriptomic analyses in idiopathic spontaneous preterm birth 0.59
CRIG identifies a novel population of highly phagocytic peritoneal macrophages associated with disease severity in patients with cirrhosis and ascites 0.59
Transcriptomic analysis of IPF lung-associated and normal peripheral blood T cells 0.58
RNA seq analysis of human macrophages after treatment of glimepiride versus empagliflozin. 0.58
Characterization of EZH2-deficient human embryonic stem cells [ChIP-seq and bulk RNA-seq] 0.56
Identification of biomarkers for amyotrophic lateral sclerosis by comprehensive analysis of exosomal mRNAs in human cerebrospinal fluid. 0.56
Therapy-induced hypoxia contributes to AML drug-resistance through BMX Kinase upregulation 0.53
CD133hi, Notchhi, DP (double positive) and DN (double negative) in GBML8 and GBML20, both patient-derived glioblastoma tumorsphere cultures 0.48
RNA-seq after siRNA targeting DDX24 applied to iHUVECs cell lines 0.47
HDAC and NFκB antagonists synergistically inhibit growth and metastatic dissemination of MYC-driven medulloblastoma 0.45
PSEN1ΔE9, APPswe and APOE4 confer disparate phenotypes in human iPSC-derived microglia 0.45
Transcriptomes of human monocytes and monocyte-derived macrophages with or without glucocorticoid treatment 0.45
HMGA2 Promotes Long-Term Engraftment and Myelo-Erythroid Differentiation of Human Hematopoietic Stem and Progenitor Cells 0.39
A code of mono-phosphorylation modulates the function of RB. 0.37
Thyroid State Regulates Gene Expression in Human Whole Blood Cells 0.36
Transcriptome-wide modulation of splicing by the exon junction complex 0.36
RNA expression profiles from HUVECs overexpressing adenovirally delivered HIF1a and HIF2a proteins 0.36
Image based identification and targeting of cancer stem cells in pancreatic adenocarcinoma (PDAC) 0.34
mRNA profiles of JMJD3 overexpression- and JMJD3 knockout- HL-60 cells 0.33
Transcriptomics profiling of CD141+ dendritic cells isolated from peripheral blood or synovial fluid of arthritis patients 0.32
Human iPSC-derived microglia assume a primary microglia-like state after transplantation into the neonatal mouse brain [Single Cell RNAseq] 0.32
RNA-seq of primary patient AML samples 0.31
MEIS2 is a novel oncogenic partner in AML1-ETO positive AML [RNA-Seq human] 0.3
MEIS2 is a novel oncogenic partner in AML1-ETO positive AML 0.3
Human colon organoids reveal distinct physiologic and oncogenic Wnt responses 0.3
Genome-wide maps of WT and over-expressing CenH3/CENP-A in Human HeLa S3 cells 0.28
RNAseq transcriptome analysis of White Blood Cells (WBCs) from individuals with and without trisomy 21 [stranded] 0.28
Molecular Signatures Associated with ZIKV Exposure in Human Cortical Neural Progenitors 0.26
Next Generation Sequencing Quantitative Analysis of Wild Type and AML1-ETO Related Fusion Circular RNA (F-CircAE) Knockdown Kasumi-1 Cells Transcriptomes 0.23
Efficient and precise editing of endogenous transcripts with SNAP-tagged ADARs 0.22
Finding missing proteins from epigenetically manipulated human cells 0.21
Alterations of the MEK/ERK, BMP, and Wnt/b-catenin pathways detected in the blood of individuals with lymphatic malformations 0.2
Next Generation Sequencing identifying the dosage compensation state in human endometrial carcinoma and adjacent tissues 0.15
Tri-mannose grafting of chitosan nanocarriers remodels the macrophage response to bacterial infection 0.13
Expression of long non-coding RNAs in autoimmunity and linkage to enhancer function and autoimmune disease risk genetic variants 0.13
Dynamic gene regulatory networks of human myeloid differentiation [RNA-seq_siRNA] 0.13
Transcription elongation regulates genome 3D structure 0.09
Modeling genome-wide transcriptional cis-regulation in n LNCaP-abl cell line after siRNA knock down of a series of gene factors [RNA-seq] 0.08
RNA-sequencing study of peripheral blood monocytes for chronic periodontitis 0.07
hNSCs siRNA NOVA2 0.06
The transcription and translation landscapes during human cytomegalovirus infection reveal novel host-pathogen interactions 0.06
E2F1 orchestrates transcriptomics and oxidative metabolism in Wharton’s jelly derived mesenchymal stem cells from growth-restricted neonates 0.05
Expression changes in MAPKi resistant M229 melanoma lines co-cultured with PD-1 overexpressing HEK293T cells [CellLine.FPKM.batch5] 0.04
RNA sequencing and pathway analysis identify important pathways involved in hypertrichosis and intellectual disability in patients with Wiedemann-Steiner syndrome 0.03
Expression analysis of the TAF1 syndrome 0.02
The chromatin modifier CHD8 targets autism risk genes during human neurodevelopment  0.01


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation